“Having a united shareholder base was instrumental in electing a Board of independent industry leaders capable of restructuring and restarting this Company. I’m thrilled to be working with such a strong and capable group of professionals. This Board has the knowledge and experience to take the MPR technology through its development and successfully into the Global Healthcare Markets.”